Evidence map›Paper›PMID 25263553›Full record

ArticleCell reports2014

Hippo signaling influences HNF4A and FOXA2 enhancer switching during hepatocyte differentiation.

Olivia Alder, Rebecca Cullum, Sam Lee, Arohumam C Kan, Wei Wei, Yuyin Yi, Victoria C Garside, Misha Bilenky, Malachi Griffith, A Sorana Morrissy and 8 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. METTL1-Mediated MAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Olivia AlderTerry Fox Laboratory, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
Rebecca CullumTerry Fox Laboratory, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
Sam LeeTerry Fox Laboratory, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
Arohumam C KanTerry Fox Laboratory, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
Wei WeiTerry Fox Laboratory, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
Yuyin YiTerry Fox Laboratory, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
Victoria C GarsideTerry Fox Laboratory, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
Misha BilenkyCanada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
Malachi GriffithCanada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
A Sorana MorrissyCanada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
Gordon A RobertsonCanada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
Nina ThiessenCanada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
Yongjun ZhaoCanada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada.
Qian ChenDepartment of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Duojia PanDepartment of Molecular Biology and Genetics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Steven J M JonesCanada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC V5A1S6, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC V5Z4H4, Canada.
Marco A MarraCanada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC V5Z4H4, Canada.
Pamela A HoodlessTerry Fox Laboratory, BC Cancer Agency, Vancouver, BC V5Z1L3, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC V5Z4H4, Canada. Electronic address: hoodless@bccrc.ca.
BC Cancer Agency · CACanada's Michael Smith Genome Sciences Centre · CAJohns Hopkins University · US

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI Rosalie Wollett · 1985 to 2026
$208.6M
CIHR FRN259575Howard Hughes Medical InstituteNCI NIH HHS P30 CA006973
6 · The paper itself

Abstract

Cell fate acquisition is heavily influenced by direct interactions between master regulators and tissue-specific enhancers. However, it remains unclear how lineage-specifying transcription factors, which are often expressed in both progenitor and mature cell populations, influence cell differentiation. Using in vivo mouse liver development as a model, we identified thousands of enhancers that are bound by the master regulators HNF4A and FOXA2 in a differentiation-dependent manner, subject to chromatin remodeling, and associated with differentially expressed target genes. Enhancers exclusively occupied in the embryo were found to be responsive to developmentally regulated TEAD2 and coactivator YAP1. Our data suggest that Hippo signaling may affect hepatocyte differentiation by influencing HNF4A and FOXA2 interactions with temporal enhancers. In summary, transcription factor-enhancer interactions are not only tissue specific but also differentiation dependent, which is an important consideration for researchers studying cancer biology or mammalian development and/or using transformed cell lines.

Indexed as

AnimalsCell DifferentiationFemaleGene ExpressionHepatocyte Nuclear Factor 3-betaHepatocyte Nuclear Factor 4HepatocytesHippo Signaling PathwayMiceMice, Inbred C57BLMice, TransgenicProtein Serine-Threonine KinasesSignal TransductionFoxa2 protein, mouseHepatocyte Nuclear Factor 3-betaHepatocyte Nuclear Factor 4Hnf4a protein, mouseProtein Serine-Threonine Kinases

Identifiers

PMID25263553
PMCPMC4612615
OpenAlexW1983601196

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.